Recombinant Human Kallikrein 8/Neuropsin Protein, CF Summary
Details of Functionality
Measured by its ability to cleave the fluorogenic peptide substrate Boc-VPR-AMC (Catalog # ES011). The specific activity is >500 pmol/min/µg, as measured under the described conditions.
Source
Mouse myeloma cell line, NS0-derived human Kallikrein 8/Neuropsin protein Gln29-Gly260, with a C-terminal 10-His tag
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Note
<1.0 EU per 1 μg of the protein by the LAL method.
Applications/Dilutions
Dilutions
Enzyme Activity
Theoretical MW
26 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
SDS-PAGE
37-39 kDa, reducing conditions
Publications
Read Publications using 2025-SE in the following applications:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
6 months from date of receipt, -20 to -70 °C as supplied.
3 months, -20 to -70 °C under sterile conditions after opening.
Buffer
Supplied as a 0.2 μm filtered solution in Tris and NaCl.
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Assay Procedure
Activation Buffer: 50 mM Tris, pH 8.0
Assay Buffer: 50 mM Tris, pH 9.0
Recombinant Human Kallikrein 8/Neuropsin (rhKLK8) (Catalog # 2025-SE)
Lysyl-Endopeptidase, 20 U/mL stock in PBS
Substrate: BOC-Val-Pro-Arg-AMC (Catalog # ES011), 10 mM stock in DMSO
Black 96-well Plate
Plate Reader with Fluorescence Read Capability
Dilute rhKLK8 to 200 µg/mL in Activation Buffer.
Dilute Lysyl-Endopeptidase to 0.4 mU/mL in Activation Buffer.
Activate rhKLK8 by combining equal volumes of diluted rhKLK8 and Lysyl-Endopeptidase.
Incubate at 37 °C for 30 minutes.
Dilute activated rhKLK8 to 1 ng/µL in Assay Buffer.
Dilute Substrate to 200 µM in Assay Buffer.
Load 50 µL of 1 ng/µL rhKLK8 into the plate, and start the reaction by adding 50 µL of 200 µM Substrate. Include a Substrate Blank containing 50 µL of Assay Buffer and 50 µL of 200 µM Substrate.
Read at excitation and emission wavelengths of 380 nm and 460 nm (top read), respectively in kinetic mode for 5 minutes.
Calculate specific activity:
Specific Activity (pmol/min/µg) =
Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU)
amount of enzyme (µg)
*Adjusted for Substrate Blank **Derived using calibration standard 7-Amino, 4-Methyl Coumarin (AMC).
Per Well:
rhKLK8: 0.050 µg
Substrate: 100 µM
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Recombinant Human Kallikrein 8/Neuropsin Protein, CF
EC 3.4.21
EC 3.4.21.118
hK8
HNP
kallikrein 8 (neuropsin/ovasin)
Kallikrein 8
kallikrein-related peptidase 8
KLK8 protein type 1
KLK8 protein type 2
KLK8
neuropsin type 1
neuropsin type 2
Neuropsin
NP
NRPN
Ovasin
PRSS19
PRSS19kallikrein-8
Serine protease 19
Serine protease TADG-14
TADG14neuropsin
Tumor-associated differentially expressed gene 14 protein
Background
Kallikrein 8 (KLK8), also known as neuropsin or ovasin, is a member of the human tissue kallikrein family (1). Two alternatively spliced forms exist, resulting in 260 (isoform 1) and 305 (isoform 2) amino acid sequences, respectively (2). Isoform 1 consists of a signal peptide (residues 1 to 28), a short pro peptide (residues 29 to 32) and the mature chain (residues 33 to 260). Isoform 2 is identical to isoform 1, except that a 45 amino acid segment is inserted in isoform 2 between residues 23 and 24 in isoform 1. Isoform 1 is predominantly expressed in pancreas whereas isoform 2 is preferentially expressed in adult brain and hippocampus, although both forms are expressed in fetal brain and placenta in comparable levels. The brain function of KLK8 seems evident in neuropsin knockout mice that showed abnormalities of synapses and neurons and predisposation to global seizure activity (3, 4). KLK8 is a novel marker for ovarian and cervical cancer carcinomas (5, 6). Recombinant human KLK8, after being activated by lysyl endopeptidase, can cleave fibronectin and several small peptide substrates (7, 8). This activity can be inhibited by recombinant human Serpin A5, recombinant human Serpin F2 and AEBSF (Catalog # 1266-PI, 1470-PI and EI001, respectively). Recombinant human KLK8 produced by R&D Systems corresponds to isoform 1.
Yousef, G.M. and E.P. Diamandis (2001) Endocrine Rev. 22:184.
Mitsui, S. et al. (1999) Eur. J. Biochem. 260:627.
Hirata, A. et al. (2001) Mol. Cell. Neurosci. 17:600.
Davies, B. et al. (2001) J. Neurosci. 21:6993.
Kishi, T. et al. (2003) Cancer Res. 63:2771.
Cane, S. et al. (2004) Am. J. Obstet. Gynecol. 190:60.
Oka, T. et al. (2002) J. Biol. Chem. 277:14724.
Shimizu, C. et al. (1998) J. Biol. Chem. 273:11189.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our Recombinant Human Kallikrein 8/Neuropsin Protein, CF and receive a gift card or discount.